• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

    8/19/24 9:00:00 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology
    Get the next $WTO alert in real time by email

    SHENZHEN, China, Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular disease management. This joint project also aims to develop a new revenue model by transitioning from the low-margin business of selling BP watches to consumers to a high-margin, recurring revenue model. This will involve selling high-margin systems using a Per Patient Per Month (PPPM) payment structure.

    Dr. Ehud Baron brings his expertise in blood pressure, hemodynamics, health mapping, and AI-driven diagnostics to this strategic collaboration. This partnership highlights UTime's new commitment to enhancing health and wellness through cutting-edge medical wearable technology. With support from strategic collaborations and advanced research, UTime strives to deliver effective global solutions for disease prevention and health management.

    Dr. Ehud Baron was a former professor at the Israel Institute of Technology, UC Berkeley, and Stanford University. He also founded and led several companies in cardiology, sleep, and AI sectors.

    In light of the heightened global emphasis on health and disease prevention following the 2019 COVID-19 pandemic, UTime has prioritized the development of advanced medical wearable products. In 2024, UTime and Dr. Ehud Baron embarked on a strategic initiative to create a new blood pressure monitoring watch utilizing Dr. Baron's continuous blood pressure measurement technology. The collaboration with Dr. Ehud Baron is expected to play a key role in advancing UTime's efforts in blood pressure monitoring solutions. Moving forward, UTime is dedicated to expanding its range of medical wearable products, leveraging Dr. Baron's expertise to meet the growing demand for advanced health technologies worldwide.

    About UTime Limited

    UTime Ltd., established in 2008, provides cost-effective mobile devices to consumers globally and to helping low-income individuals from established markets, including the United States and emerging markets such as India and other countries in South Asia and Africa have better access to updated mobile technology. Since 2024, UTime has been committed to transforming health and wellness through innovative medical wearable technologies. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management on a global scale. For more information, visit the Company's website at http://www.utimeworld.com/.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the ability of the Company to regain compliance with Nasdaq continued listing requirements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the "Risk Factors" section of the Annual Report in Form 20-F filed with the SEC on July 30, 2024. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    For more information, please contact:

    Eaky Tan

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/utime-limited-partners-with-dr-ehud-baron-to-pioneer-ai-driven-health-solutions-302225098.html

    SOURCE UTime Limited

    Get the next $WTO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WTO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Cao Honggang

    3 - UTime Ltd (0001789299) (Issuer)

    3/24/26 7:31:06 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    SEC Form 3 filed by new insider Wang Yanzhi

    3 - UTime Ltd (0001789299) (Issuer)

    3/24/26 7:24:34 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    SEC Form 3 filed by new insider Bao Minfei

    3 - UTime Ltd (0001789299) (Issuer)

    3/19/26 7:57:38 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    $WTO
    SEC Filings

    View All

    SEC Form 6-K filed by UTime Limited

    6-K - UTime Ltd (0001789299) (Filer)

    3/18/26 4:11:27 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    SEC Form 6-K filed by UTime Limited

    6-K - UTime Ltd (0001789299) (Filer)

    3/13/26 8:00:00 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    SEC Form 6-K filed by UTime Limited

    6-K - UTime Ltd (0001789299) (Filer)

    1/28/26 5:20:02 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    $WTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Covering Millions of Crypto Users, UTime Signs Non-Binding Letter of Intent to Acquire Data Platform "Feixiaohao" for Web3 Infrastructure Expansion

    SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design, development, and manufacturing of mobile devices and smart hardware products, today announced its intention to acquire 100% of the outstanding equity of Feixiaohao Technology Inc., operator of the renowned "Feixiaohao" Web3 Data Analytics & Asset Pricing Platform (feixiaohao.ai). The proposed transaction is valued at up to USD80 million, structured through a combination of USD64 million in UTime ordinary shares or convertible preferred shares and USD16 million in cash consideration. This intended acquisition, upon completion, will mark UTime's strategic entry

    3/13/26 8:00:00 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    UTime Limited Announces Reverse Stock Split

    SHENZHEN, China, Feb. 06, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today announced that its share consolidation ("Share Consolidation") involving the consolidation of every five (5) Class A ordinary shares, with a par value of US$0.10 per share, into one (1) class A ordinary share with a par value of US$0.50 per share, will take effect at 8:00 a.m. Eastern Time on February 17, 2026. The Company's Class A Ordinary shares will open for trading on the Nasdaq Capital Market on February 17, 2026, on a post-split basis, under the existing ticker symbol "WTO," with a new CUSIP number of G9411M140. Details of the Share Consolidation The Share Consolidation was approved by the Company'

    2/6/26 8:05:00 AM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    UTime Subsidiary Lands US$50 Million Smart Server Intent Agreement, Powering Next-Gen Computing Infrastructure

    SHENZHEN, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design, development, and manufacturing of mobile devices and smart hardware products, today announced that its Shenzhen-based subsidiary, Shenzhen Liandai Technology Co., Ltd. ("Shenzhen Liandai"), has entered into a strategic Intentional Order Cooperation Agreement (the "Cooperation Agreement") with Shenzhen Yunwei Digital Technology Co., Ltd. ("Shenzhen Yunwei Digital") for the potential supply of 500,000 units of smart servers, representing an estimated contract value of approximately $50 million. Under the Cooperation Agreement, Shenzhen Yunwei Digital has expresse

    2/3/26 3:45:00 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology

    $WTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by UTime Limited

    SC 13D - UTime Ltd (0001789299) (Subject)

    10/21/24 4:15:32 PM ET
    $WTO
    Consumer Electronics/Appliances
    Technology